Navigation Links
FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
Date:7/23/2008

BOSTON, July 23 /PRNewswire/ -- FluoroPharma Inc., a company developing breakthrough molecular imaging agents for the Positron Emission Tomography (PET) market, announced positive Phase I results for BFPET, its novel Fluorine-18 labeled tracer for myocardial perfusion imaging. BFPET is FluoroPharma's second cardiovascular product to complete Phase I clinical development.

BFPET is a PET imaging agent, designed to assess the blood flow in the heart (myocardial perfusion). Myocardial perfusion imaging is a standard test to assess coronary artery disease (CAD), with more than 9 million Americans undergoing the test annually. The Phase I trial, led by Principal Investigator Alan J. Fischman, MD, PhD at the Massachusetts General Hospital, was designed to evaluate safety, distribution and dosimetry of BFPET in 12 healthy subjects following a single dose injection at rest.

"BFPET Phase I data demonstrates that the agent has a favorable dosimetry and pharmacokinetics profile and is well tolerated. All safety endpoints were achieved with no adverse events and no clinically significant changes noted in follow-up clinical and laboratory testing," said Dr. Fischman, Professor of Radiology at Harvard Medical School. "Biodistribution results indicate fast blood clearance, rapid and stable myocardial uptake and high heart to background ratios."

"We are encouraged by the positive initial clinical safety results and look forward to validating BFPET's performance in the next stage of development," said Dr. David Elmaleh, FluoroPharma's founder, Chief Scientific Advisor, and Associate Professor of Radiology at Harvard Medical School. "The high quality cardiac images obtained in this study indicate that new cardiac PET imaging agents can expand the applications of PET beyond the use of FDG (2-18Fluoro-2-deoxy-D-Glucose) in oncology and neurology. With two cardiac agents in clinical development and a third in our pipeline, FluoroPharma hopes to pave the way fo
'/>"/>

SOURCE FluoroPharma Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)
2. FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... QC , Nov. 20, 2014 /CNW Telbec/ - ... to announce the following appointments: ... team in the newly created role of Chief Commercial ... BioPhotonic system using topical photoconverter gel for the treatment ... surgical and traumatic wounds, recently approved in ...
(Date:11/21/2014)... Texas , 21. November 2014 ... was sich am Morgen des 14. Februar 2014 zugetragen ... jedoch wohl kaum vergessen. Video - ... dass ich dabei war, mein morgendliches Training zu machen", ... waren zu der Zeit begeisterte Anhänger der ...
(Date:11/21/2014)... Nov. 20, 2014   Coqui RadioPharmaceuticals Corp. , ... U.S. commercial producer of Molybdenum-99 (Mo-99), is proud to ... INVAP to design its Medical Isotope Production Facility ... is the parent isotope of Technetium-99, which is used ... 2012, Congress passed legislation making it a national priority ...
Breaking Medicine Technology:KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3Coqui RadioPharmaceuticals Inks Deal With INVAP 2
(Date:11/23/2014)... NY (PRWEB) November 23, 2014 ... allege heart attacks, strokes, deep vein thrombosis and ... in a federal multidistrict litigation (MDL) underway in ... reports. , Court documents updated on November ... Litigation (JPML) show the filing of 259 lawsuits ...
(Date:11/23/2014)... This evaluation provides a basic ... programs and manufacturing technological innovation. Then, the evaluation ... gamers in information. In this part, the evaluation ... value, and 2009-2014 market shares for each company. ... globally and Chinese suppliers finish market of Femoral ...
(Date:11/23/2014)... 2014 AngelWeddingDress.com has recently ... selection of beach wedding dresses. “If you are looking ... AngelWeddingDress.com as soon as possible. Here you can enjoy ... manager says. , Holding a big marriage ceremony is ... a beautiful beach wedding dress is uppermost priority. Ophelia, ...
(Date:11/23/2014)... Columbus, OH (PRWEB) November 23, 2014 ... Schulte LLC on behalf of farmers and agribusinesses that ... Inc.’s attempts to commercialize Agrisure Viptera and Agrisure Duracade, ... have not been approved for sale in China. According ... caused China to virtually ban U.S. corn imports. Because ...
(Date:11/22/2014)... SC (PRWEB) November 23, 2014 Every ... to their communities. AlignLife experience rapid growth in the ... a very unique opportunity. AlignLife of Simpsonville ... AlignLife offices for their first annual Toy Drive. These ... charity they would support with this year's toy drive. ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2
... with lethal and disabling conditions is illegal worldwide, but in ... ,An editorial in this weeks BMJ asks ... 200,000 live births occur annually; of these, 10-20 babies ... actively killed. Yet between 1997 and 2004 only 22 such ...
... cause uncommon ailments if neglected, specialists warn. Most ... always thought it is harmless. But specialists say it could ... negatively impact vision or cause harm to any part of ... of chronic sinusitis because of unchecked pollution. Chronic sinus may ...
... a protein called tau helped in the reduction of Alzheimers ... of helping find treatment to a deadly brain disorder, ... of California, San Francisco said, If this strategy also works ... our ability" ,The researchers, whose work is published ...
... challenged sons have sought permission from India's president to end ... hope for the family. ,"With nobody to extend ... 70-year-old Hakimuddin, a resident of Kamalpur village in Bhadrak district. ... Mustaffa, 30, are stated to be suffering from a rare ...
... is no dearth of "anti-aging" products and surgeries in ... women go for them not just to enhance their looks, ... competitive enough in the market place, many observers point out. ... toxin. The toxin blocks the transmission of acetylcholine from the ...
... India, there was widespread revulsion against sex determination tests ... Association had asked its members to refrain from conducting sex-determination ... to practitioners caught in the act, the IMA had warned. ... and here comes a report that such tests are being ...
Cached Medicine News:Health News:Should the UK Adopt Dutch Rules on Euthanasia in Newborn Babies? 2Health News:A Cold Shoulder to Cold - At Your Risk 2Health News:70-year-old, Three Sons Seek Mercy Death 2Health News:More and More American Women Go for Facelifts to Get Jobs 2Health News:Now Sex Determination of Fetuses in Six Weeks in UK 2
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: